News Sentiment

AKBA sentiment intelligence

Akebia Ther news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 25 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 1.40 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

86/100 classification confidence.

Company focus 25

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+12.9% over one week, +51.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Lobbying Update: $60,000 of AKEBIA THERAPEUTICS INC. lobbying was just disclosed

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 86/100 classification
One-week reaction 12.9% Price confirming higher
Trend fit Trend inactive 51.4% over four weeks
Fair value -20.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 23
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 25
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 8
GlobeNewswire 4
Market source 4
Quiver Quantitative 2
MT Newswires 2
Seeking Alpha 1
Investing.com 1
Investing.com Canada 1

Event Lens

What the news is about

Classified themes
Market update 19
Earnings 5
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-25 of 25